Meeting
2017 ASCO Annual Meeting
Outcomes from 735 patients with breast cancer brain metastases (BM) according to biological subtype, number of BMs, and systemic treatment after local therapy.
Authors
Anna Niwinska
Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Anna Niwinska , Katarzyna Pogoda , Halina Rudnicka , Agnieszka Irena Jagiello-Gruszfeld , Sebastian Rybski , Zbigniew Nowecki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 35, 2017 (suppl; abstr 2078)
DOI
10.1200/JCO.2017.35.15_suppl.2078
Abstract #
2078
Poster Bd #
320
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Systemic therapy for patients with breast cancer and one to three brain metastases (BM).
First Author: Zaid A Soomro
Poster
2024 ASCO Genitourinary Cancers Symposium
Systemic and tumor-directed therapy for oligometastatic prostate cancer (SOLAR): A phase II trial for veterans with de novo oligometastatic prostate cancer.
First Author: Nicholas George Nickols
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: A propensity score matched study.
First Author: Michael Yan
Poster
2023 ASCO Annual Meeting
Phase I/II study of stereotactic radiosurgery with concurrent olaparib followed by adjuvant durvalumab and physician’s choice systemic therapy in patients with breast cancer brain metastases.
First Author: Colette Shen